InsidersTradesSigma
Track the Sprint Bioscience AB share price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are quoted on the FI market, under the oversight of FIN-FSA. Operating in the Health Care sector, Sprint Bioscience AB has published 2 reports. Market capitalisation: €395.7m. The latest transaction was reported on 11 December 2025 (Purchase). Among the most active insiders: Björn Sjöstrand. All data is openly available.
2
Insider Decl.
n/a
Thresholds
€24,019
2 ops.
Buy Volume
n/a
n/a
Sell Volume
19Σ signal
Fundamental score
Ranked 6 of 29,062 companies
96.7
score / 100
Value96
Quality98
FCF yld24%
Earn yld26%
EV/EBITDA3.8x
ROE154%
Gross mgn92%
Net mgn55%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 11 December 2025
Declarations2 total
30,000 shares@ €0.13320.0011% mcap16.6% of flowAktieISIN SE0006343745FI:A003U606-1
333,520 shares@ €0.060.0055% mcap83.4% of flowBTA (betald tecknad aktie)ISIN SE0016609804FI:A003N847-2
2 of 2 declarations
About Sprint Bioscience AB
Sprint Bioscience AB is a Swedish company focused on developing drugs for cancer treatment. It specializes in the discovery and development of new targeted therapies.